The Medical Device Innovation Consortium: joining public and private in the US to speed patient access to new technologies
This article was originally published in SRA
Dale Wahlstrom and Beth Lindborg explain how a new partnership between the US Food and Drug Administration and the private sector is working to validate tools and methods that will make the regulatory review process for medical devices more efficient.
You may also be interested in...
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
Through its partnership with majority stakeholder Nanjing King-Friend Biochemical Pharmaceutical, Meitheal Pharmaceuticals has received FDA approval for enoxaparin, a generic rival to Lovenox.